AST-56100

N/A

Report date: 2022/01/05 15:24:33

NME

Base Information

Drug NameAST-56100

Drug Alias NameAST-56100

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionFibroblast growth factor receptor 1 antagonistsFibroblast growth factor receptor 2 antagonistsFibroblast growth factor receptor 3 antagonists

TargetsFibroblast growth factor receptor 2Fibroblast growth factor receptor 3Fibroblast growth factor receptor 1

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesJiangsu Ellis Biomedicine Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Ellis Biomedicine Co Ltd

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A